GLP-1 medications are transforming obesity care. Without addressing inactivity and muscle loss, employers risk a new wave of MSK claims. Up to 70% of GLP-1 users discontinue within a year, and many regain weight after treatment ends.
GLP-1s can cost employers up to $10,000 per member annually, yet many of these dollars are going to members without long-term habit change.
Leading employers are solving for this risk by adding structured movement plans to support GLP-1 use and protect lean muscle mass.
In this exclusive white paper, Sword Health explores how Sword Move complements GLP-1 strategies by reinforcing sustainable physical activity. If your organization is investing in GLP-1s, this is essential reading.
Download to learn how:
- Up to 39% of lean body mass is lost during GLP-1 use
- Inactivity contributes to 27% of total employee medical spend
- Sarcopenia contributes nearly $900 in excess healthcare costs per employee each year
- 78% of Move users report feeling moderately better or much better
- 69% of active and insufficiently active members members reach active or healthy active status within 10 weeks